Bonesupport Holding AB (BOEUF) reports a robust 22% sales growth and outlines strategic plans for market expansion despite currency challenges and increased expenses.

BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the year-end report for the fourth quarter and full year 2025. "Strong growth, s ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: BONESUPPORT HOLDING AB is ...

The antibiotic-eluting CERAMENT products (CERAMENT G and CERAMENT V) showed robust growth of 59% on a last-twelve-months basis in constant currency. In contrast, the non-antibiotic CERAMENT BVF ...

Earnings call BONESUPPORT reported Q3 2025 net sales of SEK 294 million, up 24% YoY (34% in constant currency), with 59% constant currency growth in antibiotic-eluting CERAMENT products. U.S. CERAMENT ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from BONESUPPORT HOLDING AB ( ...

Bonesupport Holding AB (STO:BONEX) presented its Q2 2025 results on July 15, showing continued strong growth despite currency headwinds. The Swedish medical technology company, which specializes in ...